戈谢病肝脏与脾脏的多参数磁共振成像研究
前瞻性纳入41例1型戈谢病患者,于2019年1月至2020年2月行3.0 T MRI及MR弹性成像,评估肝脂肪分数、肝脾体积、铁沉积及肝脾硬度并与GD-DS3评分相关分析。肝大见于15%、脾大见于42%的患者;肝硬度与GD-DS3中度相关(rho=0.559,p<0.001),脾体积与GD-DS3中度相关(rho=0.524,p=0.001)。作者认为肝MRE与脾体积可能作为疾病严重程度的生物标志物。
要点
- 肝硬度与GD-DS3评分中度相关(rho=0.559,p<0.001),脾体积与GD-DS3中度相关(rho=0.524,p=0.001)。
- 肝与脾铁过载中度相关(rho=0.537,p=0.002),肝与脾体积强相关(rho=0.692,p<0.001)。
- 接受治疗的患者中肝脾肿大、肝纤维化及肝铁过载的患病率较低。
核心结论
- 接受治疗的戈谢病患者中肝脾肿大、肝纤维化及肝铁过载的患病率较低,可能与治疗的有益效应有关。
- 肝MRE与脾体积和GD-DS3评分相关,可能作为疾病严重程度的生物标志物。
研究设计与样本
- 前瞻性研究,纳入41例1型戈谢病患者,于2019年1月至2020年2月使用3.0 T MRI及MR弹性成像(MRE)评估。
- 收集临床、实验室及影像数据,采用Mann-Whitney、Kruskal-Wallis及Spearman相关分析评估肝脾MRI与MRE指标、临床实验室变量及GD-DS3评分。
- 比较酶替代治疗(ERT)与底物减少治疗(SRT)组。
关键影像表现/征象
- 肝大见于15%的患者,脾大见于42%的患者。
- 肝与脾铁过载呈中度相关(rho=0.537;p=0.002)。
- 肝与脾体积呈强相关(rho=0.692,p<0.001)。
- 肝与脾硬度呈中度相关(rho=0.453,p=0.006)。
诊断标准与关键数值
- 肝硬度与GD-DS3评分中度相关(rho=0.559;p<0.001)。
- 脾体积与GD-DS3评分中度相关(rho=0.524;p=0.001)。
临床应用与阅片要点
- 肝MRE测得的肝硬度与脾体积和GD-DS3评分相关,作者认为可能作为疾病严重程度的生物标志物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To assess liver and spleen characteristics of a population with Gaucher disease (GD) using multiparametric MRI and MR elastography (MRE) for evaluation of diffuse liver and spleen disease, which includes liver fat fraction, liver and spleen volume and iron deposition, and liver and spleen stiffness correlated with DS3 Severity Scoring System for Gaucher disease (GD-DS3).
METHODS: We prospectively evaluated 41 patients with type 1 Gaucher disease using a 3.0 T MRI and MRE between January 2019 and February 2020. Clinical, laboratory, and imaging data was collected. Mann-Whitney, Kruskal-Wallis, and Spearman's correlation were applied to evaluate liver and spleen MRI and MRE, clinical and laboratory variables, and GD-DS3. ERT and SRT treatment groups were compared.
RESULTS: Hepatomegaly was seen in 15% and splenomegaly in 42% of the population. Moderate and strong and correlations were found between liver and spleen iron overload (rho = 0.537; p = 0.002); between liver and spleen volume (rho = 0.692, p < 0.001) and between liver and spleen stiffness (rho = 0.453, p = 0.006). Moderate correlations were found between liver stiffness and GD-DS3 (rho = 0.559; p < 0.001) and between splenic volume and GD-DS3 (rho = 0.524; p = 0.001).
CONCLUSION: The prevalence of hepatosplenomegaly, liver fibrosis, and liver iron overload in treated patients with GD is low, which may be related to the beneficial effect of treatment. Liver MRE and splenic volume correlate with severity score and may be biomarkers of disease severity.
引用
- Parente DB, de Melo Malta FCM, de Souza Cravo R, et al. Multiparametric magnetic resonance imaging of the liver and spleen in Gaucher disease. Abdom Radiol (NY). 2024. PMID: 38642092. doi:10.1007/s00261-024-04293-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。